Multicountry Distribution and Characterization of Extended-spectrum β-Lactamase–associated Gram-negative Bacteria From Bloodstream Infections in Sub-Saharan Africa

Abstract

BackgroundAntimicrobial resistance (AMR) is a major global health concern, yet, there are noticeable gaps in AMR surveillance data in regions such as sub-Saharan Africa. We aimed to measure the prevalence of extended-spectrum β-lactamase (ESBL) producing Gram-negative bacteria in bloodstream infections from 12 sentinel sites in sub-Saharan Africa.MethodsData were generated during the Typhoid Fever Surveillance in Africa Program (TSAP), in which standardized blood cultures were performed on febrile patients attending 12 health facilities in 9 sub-Saharan African countries between 2010 and 2014. Pathogenic bloodstream isolates were identified at the sites and then subsequently confirmed at a central reference laboratory. Antimicrobial susceptibility testing, detection of ESBL production, and conventional multiplex polymerase chain reaction (PCR) testing for genes encoding for β-lactamase were performed on all pathogens.ResultsFive hundred and five pathogenic Gram-negative bloodstream isolates were isolated during the study period and available for further characterization. This included 423 Enterobacteriaceae. Phenotypically, 61 (12.1%) isolates exhibited ESBL activity, and genotypically, 47 (9.3%) yielded a PCR amplicon for at least one of the screened ESBL genes. Among specific Gram-negative isolates, 40 (45.5%) of 88 Klebsiella spp., 7 (5.7%) of 122 Escherichia coli, 6 (16.2%) of 37 Acinetobacter spp., and 2 (1.3%) of 159 of nontyphoidal Salmonella (NTS) showed phenotypic ESBL activity.ConclusionsOur findings confirm the presence of ESBL production among pathogens causing bloodstream infections in sub-Saharan Africa. With few alternatives for managing ESBL-producing pathogens in the African setting, measures to control the development and proliferation of AMR organisms are urgently needed.

Antimicrobial resistant and enteropathogenic bacteria in ‘filth flies’: a cross-sectional study from Nigeria

“…The intestinal colonization rate of 'filth flies' with ESBL-E was low (0.8%, 16/2,000) compared to a similar study from Germany (3.3%, 44/1346) 12 . This finding is surprising as ESBL-E rates are high both in asymptomatic carriers (33.6%, rectal) and among Enterobacterales from bloodstream infection (12.1-15%) in sub-Saharan Africa [20][21][22] .…”

Qualitative study of antibiotic prescription patterns and associated drivers in Sudan, Guinea-Bissau, Central African Republic and Democratic Republic of Congo

“…However, a multicountry study exploring the distribution of ESBL-associated Gram-negative bacteria found a sub-Saharan Africa genotypic ESBL prevalence of 9.3% and phenotypic ESBL prevalence of 12.1% based on data from nine countries, including Sudan and Guinea-Bissau. 4 We were unable to find any studies that systematically explored the drivers or prescription behaviours related to antibiotic use, which might be able to explain high levels of ABR.…”

The Severe Typhoid Fever in Africa Program Highlights the Need for Broad Deployment of Typhoid Conjugate Vaccines

“…Importantly, Toy et al summarize the prevalence of extended-spectrum β-lactamase (ESBL)–producing gram-negative bacterial isolates from 12 TSAP sites collected between 2010 and 2014 [28]. Analysis of 505 isolates showed that 12.1% demonstrated phenotypic ESBL activity, which was more prevalent in infants than in the broader population.…”